Separately, Barr Laboratories entered into a settlement agreement and a supply agreement to resolve the patent litigation regarding Boehringer Ingelheim’s Aggrenox product and Duramed Pharmaceuticals, a subsidiary of
The patent is licensed exclusively to the company by the patent’s assignee, Supernus Pharmaceuticals. Based on calculations made by the US Patent and Trademark Office, the term of
The interim analysis included patients from the first 200 to complete Maestro-01 and assessed the likelihood of the study reaching its primary endpoint at the end of the
The assay is now approved to screen donated blood, plasma, organs and tissue for the three viruses in individual blood donations or in pools of up to 16
The transaction involved a number of elements, including: BioForce licensing its scientific applications technology, including its ViriChip, Chip-on-a-Tip and CellWell diagnostic and detection systems, to Aspera in exchange
Under the contract manufacturing agreement, DPT Laboratories will provide CPEX with capacity to supply Nasulin clinical materials in volumes sufficient for the remainder of Phase II trials and
Acrux will proceed to file a marketing application in Europe, under the brand name Ellavie. Acrux said that it has already received strong commercial interest for Ellavie from
The Drug Controller General of India had accorded its approval to Venus Remedies for launch of the fourth product developed by Venus Research Center, after completion of its
Viread is now also indicated for the treatment of chronic hepatitis B in adults. The drug is administered as a once-daily tablet, and works by blocking hepatitis B
In the action letter, the FDA informed the sponsor (Astellas) that it has completed its review of the Kynapid new drug application and that the application is approvable.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.